Beroni Group (Beroni Group) FCF Margin % : -211.76% (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Beroni Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beroni Group's Free Cash Flow for the six months ended in Jun. 2023 was $-0.58 Mil. Beroni Group's Revenue for the six months ended in Jun. 2023 was $0.27 Mil. Therefore, Beroni Group's FCF Margin % for the quarter that ended in Jun. 2023 was -211.76%.

As of today, Beroni Group's current FCF Yield % is -0.50%.

The historical rank and industry rank for Beroni Group's FCF Margin % or its related term are showing as below:

BNIGF' s FCF Margin % Range Over the Past 10 Years
Min: -327.49 Med: -91.9 Max: 30.25
Current: -148.77

During the past 7 years, the highest FCF Margin % of Beroni Group was 30.25%. The lowest was -327.49%. And the median was -91.90%.

BNIGF's FCF Margin % is ranked worse than
97.29% of 516 companies
in the Conglomerates industry
Industry Median: 2.34 vs BNIGF: -148.77

Beroni Group FCF Margin % Historical Data

The historical data trend for Beroni Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group FCF Margin % Chart

Beroni Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-237.14

-208.13

-78.83

-91.86

-327.32

Beroni Group Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial									-356.40	-7.55	-895.27	-107.88	-211.76

Competitive Comparison of Beroni Group's FCF Margin %

For the Conglomerates subindustry, Beroni Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beroni Group's FCF Margin % Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Beroni Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beroni Group's FCF Margin % falls into.

Beroni Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beroni Group's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-1.905	/	0.582
	=	-327.32 %

Beroni Group's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-0.576	/	0.272
	=	-211.76 %

Beroni Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Beroni Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beroni Group (Beroni Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (OTCPK:BNIGF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380

Website

https://www.beronigroup.com

Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.